Evaluating Efficacy of Indoor Non-Pharmaceutical Interventions against COVID-19 Outbreaks with a Coupled Spatial-SIR Agent-Based Simulation Framework
Chathika Gunaratne, Rene Reyes, Erik Hemberg, Una-May O'Reilly

TL;DR
This paper introduces a coupled spatial-SIR agent-based simulation framework to evaluate indoor COVID-19 intervention strategies, revealing that reducing population size and break frequency effectively lowers infection risk.
Contribution
The study develops a novel simulation framework combining spatial movement and epidemiological models to assess intervention efficacy in indoor settings.
Findings
Lowering population size reduces infection risk.
One-way movement restrictions have minimal impact.
Reducing break frequency decreases contact network connectivity.
Abstract
Contagious respiratory diseases, such as COVID-19, depend on sufficiently prolonged exposures for the successful transmission of the underlying pathogen. It is important for organizations to evaluate the efficacy of interventions aiming at mitigating viral transmission among their personnel. We have developed a operational risk assessment simulation framework that couples a spatial agent-based model of movement with a SIR epidemiological model to assess the relative risks of different intervention strategies. By applying our model on MIT's STATA building, we assess the impacts of three possible dimensions of intervention: one-way vs unrestricted movement, population size allowed onsite, and frequency of leaving designated work location for breaks. We find that there is no significant impact made by one-way movement restrictions over unrestricted movement. Instead, we find that a…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 epidemiological studies · Data-Driven Disease Surveillance
